Publication stageIn Press Journal Pre-Proof
Presented at AACR Control/Tracking Number: 22-LB-7988-AACR
Conflicts of interest
Author Benjamin Xiaoyi Li and Xiangrong Dai are employed by Lee’s Pharmaceutical Holdings Limited. This study received funding from Lee’s Pharmaceutical Holdings Limited. The funder had the following involvement with the study Efficacy and Safety of Socazolimab with Carboplatin and Etoposide for ES-SCLC. All authors declare no other competing interests.
Zhiwei Chen and Shun Lu: Conceptualization, Methodology;Zhiwei Chen, Jiuwei Cui, Renhua Guo,and Ziming Li: Investigation, Resources; Zhiwei Chen: Writing - Original Draft; Shun Lu: Writing - Review & Editing, Supervision, Project administration. Benjamin Xiaoyi Li, Xiangrong Dai: Project administration, Funding acquisition.
User licenseCreative Commons Attribution (CC BY 4.0) |
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy